✦ LIBER ✦

De Novo Everolimus-Based Therapy in Renal Transplant Recipients: Effect on Proteinuria and Renal Prognosis

✍ Scribed by G. Loriga; M. Ciccarese; P.G. Pala; R.P. Satta; V. Fanelli; M.L. Manca; G. Serra; P. Dessole; M. Cossu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion From a Calcineurin Inhibitor-

✍ J. Morales; A. Fierro; D. Benavente; C. Zehnder; M. Ferrario; L. Contreras; C. H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Triple therapy and incidence of de novo

✍ Mr E. O. Kehinde; A. Petermann; J. D. Morgan; Z. A. Butt; P. K. Donnelly; P. S. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

396: Everolimus in de novo heart transpl

✍ A. Keogh; S.S. Wang; A. Zuckermann; H. Ross; M. Frigerio; H. Eisen; C. Bara; G. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Early Withdrawal of Calcineurin Inhibito

✍ M. Masetti; R. Montalti; G. Rompianesi; M. Codeluppi; R. Gerring; A. Romano; B. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

12-month safety and efficacy of everolim

✍ Helio Tedesco-Silva Jr; Stefan Vitko; Julio Pascual; Josette Eris; John C. Magee 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 504 KB

PUK5 ECONOMIC EVALUATION OF EVEROLIMUS W

✍ J Kósa; X Yang; É Kiss; Z Kalo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB